The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.
| Image |  |
|---|---|
| Description | scientific article published on 17 November 2017 |
| Author/s | |
| Publication date | November 20, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |